The investment division of one of Wall Street's largest banks, Morgan Stanley, has officially launched two new exchange-traded products (ETPs) — the Morgan Stanley Ethereum Trust (MSSE) and the Morgan Stanley Solana Trust (MSOL). This is a landmark event for the market, as it confirms the growing interest of traditional financial giants in second-tier altcoins.

Product Terms and Structure

Both trusts offer institutional investors direct exposure to the cryptocurrencies Ethereum and Solana with a minimum fee of 0.14%. For comparison, this is significantly lower than the average market rates for similar products, making Morgan Stanley's offering one of the most attractive from a cost perspective.

A key feature is that a portion of the assets placed in the trusts will be allocated to staking. At the same time, Morgan Stanley will not retain the rewards received, which is an extremely rare practice in the market. Typically, ETP issuers keep up to 25-30% of staking income, but here we see a fully transparent model that benefits holders.

Market Analysis

The launch of MSSE and MSOL is not just an expansion of the product line. It is a clear signal that Morgan Stanley sees long-term potential in Ethereum and Solana as core assets for institutional portfolios. The choice of Solana is particularly telling: despite the network's past volatility, the bank is betting on its speed and scalability.

From a professional analysis standpoint, the 0.14% fee and the waiver of staking reward retention place Morgan Stanley in an advantageous position compared to competitors like Grayscale or Bitwise. This could trigger a wave of fee reductions across the market, ultimately benefiting all participants.

My expert opinion: This move by Morgan Stanley is not just another ETP, but a strategic bid for leadership in the institutional crypto services segment. If the bank continues in this vein, we may see other Wall Street "blue chips" begin to revise their fee policies. For the market, this is unequivocally a positive signal, especially amid regulatory uncertainty.